Advertisement

Topics

GSK's COPD Triple Combo To Challenge Chiesi's Trimbow In EU

07:26 EDT 13 Sep 2017 | SCRIP

GSK's closed triple combination for COPD, Trelegy, is expected to get a greenlight for approval in Europe on Friday –...

      

Related Stories

 

Original Article: GSK's COPD Triple Combo To Challenge Chiesi's Trimbow In EU

NEXT ARTICLE

More From BioPortfolio on "GSK's COPD Triple Combo To Challenge Chiesi's Trimbow In EU"

Quick Search
Advertisement
 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...